Litcius/Paper detail

Development, characterization, and optimization of folate-chitosan surface-modified PLGA-decorated mesoporous silica nanoparticles for effective delivery of leflunomide for the management of rheumatoid arthritis

Walaa A. El‐Dakroury, Fatma Sa’eed El-Tokhy, Gihan F. Asaad, Marwa E. Shabana, Kareem H Elsyed, Haya A Elshafei, Mostafa M. Mohamed, Mohamed A. Radwan, Abdelrahman R. Said

2025European Journal of Pharmaceutics and Biopharmaceutics7 citationsDOI

Topics & Concepts

PLGALeflunomideBioavailabilityChitosanPharmacologyChemistryMesoporous silicaRheumatoid arthritisNanoparticleOral administrationArthritisDrug deliveryMaterials scienceNanotechnologyMesoporous materialMedicineImmunologyBiochemistryCatalysisRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchAutoimmune and Inflammatory Disorders Research
Development, characterization, and optimization of folate-chitosan surface-modified PLGA-decorated mesoporous silica nanoparticles for effective delivery of leflunomide for the management of rheumatoid arthritis | Litcius